PATENT CLAIM ANALYSIS

Application Number: 16303980
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["424", "275100"]

Abstract:
The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.

Claim (Index 25):
A method of treating allergy in a patient, where signs and/or symptoms of said allergy are elicited in the patient by exposure to house dust mites or storage mites and/or exposure to at least one protein allergen present in house dust mites or storage mites, the method comprising administering, to the patient, a therapeutically effective amount of a polypeptide comprising or consisting of\n (a) an amino acid sequence of SEQ ID NO: 41 or 42, or (b) an amino acid sequence consisting of at least or exactly 12 contiguous amino acid residues from the amino acid sequence of (a), or (c) an amino acid sequence having a sequence identity of at least 94% with the amino acid sequence of (a), or (d) an amino acid sequence having a sequence identity of at least 94% with the amino acid sequence of (b).

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.36842
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15021775', '15532256', '13990858', '12673412', '09662293']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6883237218265568
- 35 USC 102 Novelty (BERT): 0.5076733130386175
- Combined Prediction Score: 0.6702586809477629
- Mean Citation Score: 242.401526
- Max Citation Score: 247.44324
- Similarity Product: 172.07760403531552

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test